Kalshi to allow bets on clinical trials, FDA decisions

Source: Reuters

Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA regulatory reviews, it said on ​Thursday, making drug-development odds public for the first time.

The ‌new markets will be launched in partnership with AppliedXL, which monitors and predicts the outcomes of clinical trials.

-snip-

People will be ⁠able to bet only on the outcomes of late-stage ​trials as a part of the pilot program. Kalshi and ​AppliedXL will list a contract only after a trial finishes enrolling.

Each contract will be based on details of a named public document — the ​registered primary endpoint on ClinicalTrials.gov, the FDA approval letter ​or the voting record of the agency's advisory committee.

-snip-

Read more: https://www.reuters.com/legal/litigation/kalshi-allow-bets-clinical-trials-fda-decisions-2026-07-16/

---

Such a waste of money. Except for insiders keeping their participation secret while they separate fools from their money.

And of course Trump Jr., a complete fool but a well-connected one, will make more money because of the Kalshi shares he was given when he became a "strategic adviser" last year.